Hugh Rogers, Xphyto Therapeutics (XPHY.C) CEO and director, explains the company’s innovative three-pronged business plan involving diagnostics and drug delivery as well as the company’s potential and longevity in a post covid world. Tune in!
Latest News
Soma Gold Corp (SOMA.V) drills, mills, and produces gold in Colombia
Quimbaya Gold’s (QIM.C) CEO will buy his stock if you won’t
Salt, hydrogen, or uranium? Atco Mining (ATCO.C) hits all three
Prospera Energy (PEI.V) goes to borrowers again as boe/d drops 20%
Argo Living Soils (ARGO.C) creates carbon rich biochar.. could that be turned into graphene?
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400% in a month
